U.S. Food and Drug Administration Approves Opdivo® (nivolumab) for the Adjuvant Treatment of Patients with High-Risk Urothelial Carcinoma. 08/20/2021.
Monday, August 23, 2021
for the Adjuvant Treatment of Patients with High-Risk Urothelial Carcinoma - Bristol Myers Squibb
No food shortages, starvation deaths during COVID: Piyush Goyal. http://dlvr.it/SDDsHJ
A combination of sensors, blockchain technology, and the cloud is poised to deliver almost real-time tracking of food as it leaves a farm or...
The organic, natural, and non-GMO food marketing labels differ in terms of what they mean and whether they are certified and inspected by .....
The Northern Cohort launched the roll out of its plan for a food hub in the Peace region on Wednesday, which would see local producers work ...